Table 1. Distribution of individual characteristics of patients with pancreatic cancer in the Netherlands across different socioeconomic groups. (n = 34,757).
Low SES | Intermediate SES | High SES | ||||||
---|---|---|---|---|---|---|---|---|
% | 95% CI | % | 95% CI | % | 95% CI | p-value | ||
Gender | Male | 48 | 47–49 | 50 | 49–51 | 50 | 49–51 | 0.02 |
Female | 52 | 51–53 | 50 | 49–51 | 50 | 49–51 | ||
Age | <30 | 0.1 | 0.0–0.1 | 0.1 | 0.0–0.1 | 0.1 | 0.0–0.1 | 0.006 |
30–44 | 1.9 | 1.6–2.2 | 2.0 | 1.7–2.2 | 2.2 | 2.0–2.5 | ||
45–59 | 16 | 15–17 | 17 | 16–17 | 18 | –17-18 | ||
60–74 | 43 | 42–44 | 44 | 43–45 | 44 | 43–45 | ||
75+ | 39 | 38–40 | 37 | 36–38 | 37 | 36–38 | ||
Tumorlocalization | Head | 68 | 67–69 | 69 | 68–69 | 68 | 67–68 | 0.009 |
Non-head | 18 | 18–19 | 18 | 17–19 | 20 | 19–21 | ||
Overlapping lesion/nos | 13 | 13–14 | 14 | 13–14 | 13 | 12–13 | ||
Differentiation | Well | 3.06 | 2.7–3.4 | 3.2 | 2.9–3.5 | 2.9 | 2.5–3.2 | 0.015 |
Moderate | 10 | 10–11 | 11 | 10–11 | 11 | 11–12 | ||
Poor | 10 | 10–11 | 11 | 11–12 | 11 | 28–30 | ||
Undifferentiated | 0.7 | 0.60.9 | 0.7 | 0.5–0.8 | 0.7 | 0.5–0.8 | ||
Unknown | 76 | 75–77 | 74 | 74–75 | 74 | 73–75 | ||
Stage | local | 14 | 14–15 | 14 | 13–14 | 13 | 12–13 | 0.02 |
Beyond pancreas | 28 | 27–29 | 28 | 28–29 | 29 | 28–30 | ||
metastatic | 45 | 44–46 | 45 | 44–46 | 45 | 44–46 | ||
Unknown | 13 | 12–13 | 13 | 12–13 | 14 | 13–15 | ||
Resection | No | 91 | 90–10 | 90 | 90–91 | 90 | 89–90 | 0.006 |
Yes | 9 | 9–10 | 10 | 9–10 | 10 | 10–11 |